These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21764891)

  • 1. Sexually transmitted infection in HIV-positive men with erectile dysfunction using phosphodiesterase-5 inhibitors.
    McCarty EJ; Quinn K; Dinsmore WW
    Sex Transm Infect; 2011 Oct; 87(6):455. PubMed ID: 21764891
    [No Abstract]   [Full Text] [Related]  

  • 2. Does erectile dysfunction drug use contribute to risky sexual behavior?
    Hellstrom WJ
    Asian J Androl; 2010 Sep; 12(5):626-7. PubMed ID: 20818401
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of erection enhancing medication and party drugs among men living with HIV in Europe.
    De Ryck I; Van Laeken D; Noestlinger C; Platteau T; Colebunders R
    AIDS Care; 2013 Aug; 25(8):1062-6. PubMed ID: 23244618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of erectile dysfunction medication and unsafe sex among HIV+ men who have sex with men in care.
    Marks G; Richardson JL; Milam J; Bolan R; Stoyanoff S; McCutchan A
    Int J STD AIDS; 2005 Mar; 16(3):271-2. PubMed ID: 15829033
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of erectile dysfunction course on its progress and efficacy of treatment with phosphodiesterase type 5 inhibitors.
    Liu DF; Jiang H; Hong K; Zhao LM; Tang WH; Ma LL
    Chin Med J (Engl); 2010 Nov; 123(22):3258-61. PubMed ID: 21163126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer phosphodiesterase inhibitors: comparison with established agents.
    McNamara ER; Donatucci CF
    Urol Clin North Am; 2011 May; 38(2):155-63. PubMed ID: 21621082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insurance coverage for erectile dysfunction drugs.
    Hornbrook MC; Holup J
    Clin Pharmacol Ther; 2011 Jan; 89(1):19-21. PubMed ID: 21170065
    [No Abstract]   [Full Text] [Related]  

  • 8. Summaries for patients. Sexually transmitted diseases among men who use erectile dysfunction drugs.
    Ann Intern Med; 2010 Jul; 153(1):I-44. PubMed ID: 20621896
    [No Abstract]   [Full Text] [Related]  

  • 9. Do men with mild erectile dysfunction have the same risk factors as the general erectile dysfunction clinical trial population?
    Lee JC; Bénard F; Carrier S; Talwar V; Defoy I
    BJU Int; 2011 Mar; 107(6):956-60. PubMed ID: 20950304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual history taking and sexually transmitted infection screening in patients initiating erectile dysfunction medication therapy.
    Holman KM; Carr JA; Baddley JW; Hook EW
    Sex Transm Dis; 2013 Nov; 40(11):836-8. PubMed ID: 24113402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A state of art review on vardenafil in men with erectile dysfunction and associated underlying diseases.
    Chung E; Broc GB
    Expert Opin Pharmacother; 2011 Jun; 12(8):1341-1348. PubMed ID: 21548725
    [No Abstract]   [Full Text] [Related]  

  • 12. [Erectile dysfunction. Another option].
    Sabourin G
    Perspect Infirm; 2011; 8(6):56. PubMed ID: 22097429
    [No Abstract]   [Full Text] [Related]  

  • 13. Sexually transmitted diseases in 1161 HIV-positive patients: a 38-month prospective study in southern Spain.
    Muñoz-Pérez MA; Rodriguez-Pichardo A; Camacho Martinez F
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):221-6. PubMed ID: 9883433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do phosphodiesterase 5 inhibitors promote onward transmission of HIV in men who have sex with men?
    Richardson D; Goldmeier D; Bell C; Lamba H
    Sex Transm Infect; 2007 Jun; 83(3):250. PubMed ID: 17569725
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlations with satisfaction measures in men treated with phosphodiesterase inhibitors for erectile dysfunction.
    Mulhall JP; Kaminetsky JC; Althof SE; Goldstein I; Creanga DL; Marfatia A; Symonds T; Budhwani M
    Am J Mens Health; 2011 May; 5(3):261-71. PubMed ID: 21406491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of erectile dysfunction].
    Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2010 Sep; 39(5):385-90. PubMed ID: 20818688
    [No Abstract]   [Full Text] [Related]  

  • 17. The continuing evolution of research on sexually transmitted infections among men who have sex with men.
    Stall R; Hart G
    Sex Transm Infect; 2008 Nov; 84(6):407-9. PubMed ID: 19028935
    [No Abstract]   [Full Text] [Related]  

  • 18. Avanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction.
    Limin M; Johnsen N; Hellstrom WJ
    Expert Opin Investig Drugs; 2010 Nov; 19(11):1427-37. PubMed ID: 20939743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, double-blind, placebo-controlled study of sildenafil citrate in Canadian men with erectile dysfunction and untreated symptoms of depression, in the absence of major depressive disorder.
    Kennedy SH; Dugré H; Defoy I
    Int Clin Psychopharmacol; 2011 May; 26(3):151-8. PubMed ID: 21471773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brachial artery flow mediated assessment: a tool to predict the response to chronic PDE5 inhibition with tadalafil in patients with erectile dysfunction.
    Mancini M; Guazzi M; Bianco E; Colpi GM
    Int J Cardiol; 2011 Feb; 146(3):471-2. PubMed ID: 21194760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.